Literature DB >> 10699889

Effect of viral status on recurrence after liver resection for patients with hepatitis B virus-related hepatocellular carcinoma.

S Kubo1, K Hirohashi, H Tanaka, T Tsukamoto, T Shuto, T Yamamoto, T Ikebe, K Wakasa, S Nishiguchi, H Kinoshita.   

Abstract

BACKGROUND: Risk factors for recurrence after resection of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) require more precise definition.
METHODS: Forty patients who underwent liver resection for HBV-related HCC were studied. Their clinical findings, laboratory data (including viral status), pathologic findings, and operative methods were evaluated for recurrence risk in univariate and multivariate analyses.
RESULTS: The HB envelope (HBe) antigen, wild-type HBV, intrahepatic metastases, elevated serum activities of aspartate aminotransferase and alanine aminotransferase, and moderately or severely active hepatitis were more likely to be found in patients with a high viral load than in patients with a low viral load. Precore mutant-type HBV was more likely to be found in patients with a low viral load than in patients with a high viral load. The platelet count was significantly lower in the patients with a high viral load. A high viral load, the presence of wild-type HBV, the absence of anti-HBe, the absence of precore mutant-type HBV, Child score B, a low platelet count, and a positive surgical margin were risk factors for recurrence in univariate analysis. A nonanatomic resection tended to be a risk factor. A high viral load and positive surgical margin were independent risk factors for recurrence.
CONCLUSIONS: The measurement of viral load and detection of anti-HBe, wild-type HBV, and precore mutant-type HBV are useful for estimating a patient's prognosis after resection of HBV-related HCC. Copyright 2000 American Cancer Society.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10699889     DOI: 10.1002/(sici)1097-0142(20000301)88:5<1016::aid-cncr10>3.0.co;2-v

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  33 in total

1.  Effect of the presence of hepatitis B e antigen on prognosis after liver resection for hepatocellular carcinoma in patients with chronic hepatitis B.

Authors:  Shoji Kubo; Kazuhiro Hirohashi; Osamu Yamazaki; Mitsuharu Matsuyama; Hiromu Tanaka; Katsuhiko Horii; Taichi Shuto; Takatsugu Yamamoto; Shuichi Kawai; Kenichi Wakasa; Shuhei Nishiguchi; Hiroaki Kinoshita
Journal:  World J Surg       Date:  2002-02-19       Impact factor: 3.352

Review 2.  Survival after anatomic resection versus nonanatomic resection for hepatocellular carcinoma: a meta-analysis.

Authors:  Jinggui Chen; Kai Huang; Jianghong Wu; Huiyan Zhu; Yingqiang Shi; Yanong Wang; Guangfa Zhao
Journal:  Dig Dis Sci       Date:  2010-11-17       Impact factor: 3.199

3.  Clinical features of hepatitis B virus-related hepatocellular carcinoma.

Authors:  Toru Ishikawa
Journal:  World J Gastroenterol       Date:  2010-05-28       Impact factor: 5.742

4.  Traditional Chinese medicine syndromes of chronic hepatitis B with precore mutant.

Authors:  Hong-Zhi Yang; Jian-An Zhao; Min Dai; Yong-Wei Li; Yong-Ze Wang; Wei-Bing Guan; He-Ping Xie
Journal:  World J Gastroenterol       Date:  2005-04-07       Impact factor: 5.742

Review 5.  Adjuvant treatment strategy after curative resection for hepatocellular carcinoma.

Authors:  Wei Zhang; Bixiang Zhang; Xiao-Ping Chen
Journal:  Front Med       Date:  2021-03-23       Impact factor: 4.592

6.  Level of hepatitis B surface antigen might serve as a new marker to predict hepatocellular carcinoma recurrence following curative resection in patients with low viral load.

Authors:  Hua-Bang Zhou; Qiao-Mei Li; Zheng-Rong Zhong; Jing-Yi Hu; Xiao-Lan Jiang; Hao Wang; Hui Wang; Bing Yang; He-Ping Hu
Journal:  Am J Cancer Res       Date:  2015-01-15       Impact factor: 6.166

7.  Influence of serum HBV DNA load on recurrence of hepatocellular carcinoma after treatment with percutaneous radiofrequency ablation.

Authors:  Tadashi Goto; Haruhiko Yoshida; Ryosuke Tateishi; Kenichiro Enooku; Eriko Goto; Takahisa Sato; Takamasa Ohki; Ryota Masuzaki; Jun Imamura; Shuichiro Shiina; Kazuhiko Koike; Masao Omata
Journal:  Hepatol Int       Date:  2011-01-25       Impact factor: 6.047

8.  Liver cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study.

Authors:  Behnoosh R Momin; Paulo S Pinheiro; Helena Carreira; Chunyu Li; Hannah K Weir
Journal:  Cancer       Date:  2017-12-15       Impact factor: 6.860

9.  Twenty-year survivors after resection for hepatocellular carcinoma-analysis of 53 cases.

Authors:  Xin-Da Zhou; Zhao-You Tang; Zeng-Chen Ma; Jia Fan; Zhi-Quan Wu; Lun-Xiu Qin; Jian Zhou; Yao Yu; Hui-Chuan Sun; Shuang-Jian Qiu
Journal:  J Cancer Res Clin Oncol       Date:  2009-03-18       Impact factor: 4.553

10.  Efficacy of Nucleoside Analogs for Chronic Hepatitis B Virus-Related Hepatocellular Carcinoma After Curative Treatment: A Meta-Analysis.

Authors:  Guangcong Zhang; Xiangnan Yu; Peng Liu; Xiaoxi Huang; Xuemei Jiang
Journal:  Dig Dis Sci       Date:  2018-08-23       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.